Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Mosnodenvir

Copy Product Info
😃Good
Catalog No. T79141LCas No. 2043343-94-6
Alias JNJ-1802, JNJ 64281802

Mosnodenvir (JNJ-1802) is a pan-DENV inhibitor effective against all four serotypes of dengue viruses, with the advantage of being highly potent and orally bioavailable, and blocks viral replication by inhibiting the formation of the complex between NS3 and NS4B.

Mosnodenvir

Mosnodenvir

Copy Product Info
😃Good
Purity: 99.72%
Catalog No. T79141LAlias JNJ-1802, JNJ 64281802Cas No. 2043343-94-6
Mosnodenvir (JNJ-1802) is a pan-DENV inhibitor effective against all four serotypes of dengue viruses, with the advantage of being highly potent and orally bioavailable, and blocks viral replication by inhibiting the formation of the complex between NS3 and NS4B.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$154-In Stock
5 mg$325-In Stock
10 mg$513-In Stock
25 mg$872-In Stock
50 mg$1,310-In Stock
100 mg$1,960-In Stock
1 mL x 10 mM (in DMSO)$416-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.72%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Mosnodenvir (JNJ-1802) is a pan-DENV inhibitor effective against all four serotypes of dengue viruses, with the advantage of being highly potent and orally bioavailable, and blocks viral replication by inhibiting the formation of the complex between NS3 and NS4B.
Targets&IC50
SARS-CoV-2 BA.5:0.27 μM (EC₅₀), SARS-CoV-2 XBB:0.43 μM (EC₅₀)
In vitro
Mosnodenvir inhibited SARS-CoV-2 BA.5 and XBB in Vero E6 cells with EC₅₀ values of 0.27 μM and 0.43 μM, respectively, and showed broad-spectrum antiviral activity in other cell lines[1].
In vivo
In hACE2 transgenic mice, Mosnodenvir (200 mg/kg, i.p., daily × 5 days) reduced lung viral titers by >99% and alleviated lung damage, with good oral bioavailability (>80%)[1].
SynonymsJNJ-1802, JNJ 64281802
Chemical Properties
Molecular Weight582.98
FormulaC26H22ClF3N2O6S
Cas No.2043343-94-6
SmilesC(C(NC1=CC(S(C)(=O)=O)=CC(OC)=C1)C2=C(OC)C=C(Cl)C=C2)(=O)C=3C=4C(NC3)=CC=C(OC(F)(F)F)C4
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Mosnodenvir | purchase Mosnodenvir | Mosnodenvir cost | order Mosnodenvir | Mosnodenvir chemical structure | Mosnodenvir in vivo | Mosnodenvir in vitro | Mosnodenvir formula | Mosnodenvir molecular weight